Louise Wang Zhiying Humphrey

Array ( [id] => 7069045 [patent_doc_number] => 20050244428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)' [patent_app_type] => utility [patent_app_number] => 10/514761 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 10589 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244428.pdf [firstpage_image] =>[orig_patent_app_number] => 10514761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020369 [patent_doc_number] => 20050222388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Fusion protein of hiv regulatory/accessory proteins' [patent_app_type] => utility [patent_app_number] => 10/514740 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7595 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222388.pdf [firstpage_image] =>[orig_patent_app_number] => 10514740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880537 [patent_doc_number] => 20060029619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter' [patent_app_type] => utility [patent_app_number] => 10/514922 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6147 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029619.pdf [firstpage_image] =>[orig_patent_app_number] => 10514922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469954 [patent_doc_number] => 20040121316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Method and compositions for identifying anti-HIV therapeutic compounds' [patent_app_type] => new [patent_app_number] => 10/424186 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 195882 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121316.pdf [firstpage_image] =>[orig_patent_app_number] => 10424186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613887 [patent_doc_number] => 20060115815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Method and compositions for identifying anti-hiv therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/511183 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 195758 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115815.pdf [firstpage_image] =>[orig_patent_app_number] => 10511183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432465 [patent_doc_number] => 20040002103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Synthetic ligation reassembly in directed evolution' [patent_app_type] => new [patent_app_number] => 10/422523 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 58054 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002103.pdf [firstpage_image] =>[orig_patent_app_number] => 10422523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7151849 [patent_doc_number] => 20040171803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Artificial protein having potentiated immunogenicity of epitope' [patent_app_type] => new [patent_app_number] => 10/398932 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8896 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171803.pdf [firstpage_image] =>[orig_patent_app_number] => 10398932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809007 [patent_doc_number] => 20030198946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Hepatitis-C virus testing' [patent_app_type] => new [patent_app_number] => 10/396964 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17960 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198946.pdf [firstpage_image] =>[orig_patent_app_number] => 10396964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633078 [patent_doc_number] => 20030211470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'CD4-IgG2-based salvage therapy of HIV-1 infection' [patent_app_type] => new [patent_app_number] => 10/386763 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 21462 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211470.pdf [firstpage_image] =>[orig_patent_app_number] => 10386763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991606 [patent_doc_number] => 20050090643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity' [patent_app_type] => utility [patent_app_number] => 10/505666 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5786 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090643.pdf [firstpage_image] =>[orig_patent_app_number] => 10505666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7039275 [patent_doc_number] => 20050158709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods for determinging the influence of protein binding on antiretroviral activity' [patent_app_type] => utility [patent_app_number] => 10/504675 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7211 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158709.pdf [firstpage_image] =>[orig_patent_app_number] => 10504675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679073 [patent_doc_number] => 20030229214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Vaccines comprising synthetic genes' [patent_app_type] => new [patent_app_number] => 10/369121 [patent_app_country] => US [patent_app_date] => 2003-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21866 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229214.pdf [firstpage_image] =>[orig_patent_app_number] => 10369121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 382846 [patent_doc_number] => 07306798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Immunoglobulin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same' [patent_app_type] => utility [patent_app_number] => 10/504802 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9180 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/306/07306798.pdf [firstpage_image] =>[orig_patent_app_number] => 10504802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982850 [patent_doc_number] => 20050152920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof' [patent_app_type] => utility [patent_app_number] => 10/502359 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12882 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152920.pdf [firstpage_image] =>[orig_patent_app_number] => 10502359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843149 [patent_doc_number] => 20030148496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'HIV capsid assembly-associated compositions and method' [patent_app_type] => new [patent_app_number] => 10/346654 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14404 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148496.pdf [firstpage_image] =>[orig_patent_app_number] => 10346654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7195433 [patent_doc_number] => 20050164164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Hiv-1 virus tat-protein mutants' [patent_app_type] => utility [patent_app_number] => 10/501223 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9281 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164164.pdf [firstpage_image] =>[orig_patent_app_number] => 10501223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183447 [patent_doc_number] => 08623379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Compositions and methods for generating an immune response' [patent_app_type] => utility [patent_app_number] => 10/336566 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 72 [patent_no_of_words] => 20823 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10336566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797815 [patent_doc_number] => 20030176689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Inhibitors of hepatitis C virus protease' [patent_app_type] => new [patent_app_number] => 10/319402 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17416 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176689.pdf [firstpage_image] =>[orig_patent_app_number] => 10319402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379962 [patent_doc_number] => 20040081636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Lentiviral vectors for the preparation of immunotherapeutical compositions' [patent_app_type] => new [patent_app_number] => 10/313038 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8300 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081636.pdf [firstpage_image] =>[orig_patent_app_number] => 10313038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362689 [patent_doc_number] => 20040005330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Mutated HIV Tat' [patent_app_type] => new [patent_app_number] => 10/310740 [patent_app_country] => US [patent_app_date] => 2002-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9739 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005330.pdf [firstpage_image] =>[orig_patent_app_number] => 10310740 [rel_patent_id] =>[rel_patent_doc_number] =>)